-
Primary Research and View of the Future
“View of the Future.” It’s critical to understand the current landscape for each client’s service offerings, but understanding what respondents recognize as key headwinds and tailwinds in the next 5 years is imperative.” Click here to read the full How To article.
-
The Disruptor26 Podcast Series with Paul Garofolo
Locus Biosciences is revolutionizing the treatment of bacterial disease using its CRISPR-Cas3 technology to kill targeted bacteria while leaving the many species of good bacteria in the body unharmed. Listen to Kineticos Founder and CEO Shailesh Maingi and Paul Garofolo, CEO of Locus Biosciences as they discuss the past, present, and future of Locus Biosciences … Continue reading The Disruptor26 Podcast Series with Paul Garofolo
-
2020 Q1 BCI – Fundamentals of Running a Biopharmaceutical
The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy. The BCI measures c-suite and executive leadership sentiment in the biopharma industry asking questions about their confidence levels concerning key issues. We look for the BCI to become a valuable and highly sought-after resource for … Continue reading 2020 Q1 BCI – Fundamentals of Running a Biopharmaceutical
-
The Role of Confirmation Bias in Decision Making
Written by Abe Maingi, VP of Precision Medicine, Kineticos Confirmation bias is our tendency to search for and favor all information that confirms our beliefs while ignoring or devaluing information that contradicts our beliefs. According to Tufts University research, “If one were to attempt to identify a single problematic aspect of human reasoning that deserves attention above all … Continue reading The Role of Confirmation Bias in Decision Making
-
Are we Manufacturing the right T-Cells And a Look at the Future of Oncology Precision Medicine
The final part of the discussion between Kineticos’ Operating Executive, Steve Buckanavage and Precision Biosciences’ CMO, Christopher Heery M.D., covers the advancement of T-cell generation and what the future holds for Oncology research. Click the link below to view the whole article. Moderator: Steve Buckanavage, Operating Executive, Kineticos Panelist: Christopher Heery, CMO, Precision Biosciences Kineticos: … Continue reading Are we Manufacturing the right T-Cells And a Look at the Future of Oncology Precision Medicine
-
Is Precision Medicine in Oncology Narrowing Patient Population Too Much?
Kineticos’ Operating Executive Steve Buckanavage, continues his discussion with Christopher Heery, M.D., CMO at Precision Biosciences as they tackle the difficulties that Precision Medicine can bring to Oncology studies. To read the whole article, click the link below. Moderator: Steve Buckanavage, Operating Executive, Kineticos Panelist: Christopher Heery, M.D., CMO, Precision Biosciences Kineticos: Our understanding of … Continue reading Is Precision Medicine in Oncology Narrowing Patient Population Too Much?
The Precision Medicine practice at Kineticos helps diagnostic companies— including labs and tools companies—maximize their commercial potential at the corporate and product levels while ensuring companies operate in an efficient manner.
The Precision Medicine practice at Kineticos supports clients across three service areas including:
Corporate Strategy and Development
- Market, Competitor, Customer Assessments
- Go-to-Market Strategy
- Mergers and Acquisitions
- Licensing and Acquisitions
Commercial Strategy
- Technology Assessment
- R&D Innovation Strategy
- Co-Development Models
Click the Tabs Below for Precision Medicine Practice Case Studies
Corporate Strategy and Development
-
Market Opportunity Assessment
Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their service offerings. Kineticos was asked to analyze market, competitive, customer, and pipeline segments for each market, ultimately providing the client with recommendations on which service offerings to strategically prioritize. NOTE: Use the tool-bar located at … Continue reading Market Opportunity Assessment
-
503B Compounding Pharmacy Market Assessment
Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was interested in assessing current market dynamics, key competitors, generating customer feedback via primary research survey and KOL interviews, and an analysis of the current regulatory landscape with the ultimate go/no-go recommendation to enter the market. … Continue reading 503B Compounding Pharmacy Market Assessment
-
Primary Research Study
Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to support the client’s investment slide deck. As a follow-on project to an initial primary research study, an emerging company with a disruptive platform technology retained Kineticos to conduct a primary research study of secondary markets for their … Continue reading Primary Research Study
-
Contract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand the market dynamics of the different areas in the CDMO market. Kineticos was contracted to conduct 3 separate voice of customer studies in order to gain nuances into each of the separate market dynamics. For … Continue reading Contract Development and Manufacturing Due Diligence
-
Go-to-Market Strategy and Tactical Deployment Plan
Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively entering a competitive market while achieving an aggressive growth goal. The primary project objective was to help the company better understand the market opportunity and build a strategic, yet actionable Go-to-Market plan. Process: Leveraging a bottom … Continue reading Go-to-Market Strategy and Tactical Deployment Plan
-
Voice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader and requested that Kineticos provide them with a comprehensive overview of customer needs. Specifically, the sponsor needed insight into what current competitive offerings being utilized, competitive product codes, and a variety of insights regarding customer’s … Continue reading Voice of Customer Study
Technology and Innovation
-
Contract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand the market dynamics of the different areas in the CDMO market. Kineticos was contracted to conduct 3 separate voice of customer studies in order to gain nuances into each of the separate market dynamics. For … Continue reading Contract Development and Manufacturing Due Diligence
-
Go-to-Market Strategy and Tactical Deployment Plan
Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively entering a competitive market while achieving an aggressive growth goal. The primary project objective was to help the company better understand the market opportunity and build a strategic, yet actionable Go-to-Market plan. Process: Leveraging a bottom … Continue reading Go-to-Market Strategy and Tactical Deployment Plan
-
Voice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader and requested that Kineticos provide them with a comprehensive overview of customer needs. Specifically, the sponsor needed insight into what current competitive offerings being utilized, competitive product codes, and a variety of insights regarding customer’s … Continue reading Voice of Customer Study
-
Go-To-Market Strategy
Situation: As a follow up to a pricing study, Kineticos was retained by a specialty laboratory to develop a comprehensive strategy designed to help the client double in revenue in the next 4 years. This engagement was split into two phases: the first phase was data gathering on key competitive, market, pipeline, and technology intelligence, … Continue reading Go-To-Market Strategy
-
Business Planning and Launch
Situation: An emerging concierge patient healthcare services company was nearing launch and requested that Kineticos support the final stages of business planning along with launch. Process: Kineticos first developed and launched an online survey with the goal of identifying key tests/services to offer, drivers to purchase, barriers to entry, etc. The planning support also included a … Continue reading Business Planning and Launch
-
Analysis of Diagnostic Adoption Patterns
Situation: A biotech company developing a non-invasive cancer diagnostic was seeking support in gaining a comprehensive understanding of physicians’ adoption patterns related to their leading oncology product candidate. Thus, Kineticos was asked to provide key insight into customer product requirements and adoption rates. Process: To ensure the diagnostic met physician needs, Kineticos launched a study designed to … Continue reading Analysis of Diagnostic Adoption Patterns
Operational Excellence
-
Contract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand the market dynamics of the different areas in the CDMO market. Kineticos was contracted to conduct 3 separate voice of customer studies in order to gain nuances into each of the separate market dynamics. For … Continue reading Contract Development and Manufacturing Due Diligence
-
Voice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader and requested that Kineticos provide them with a comprehensive overview of customer needs. Specifically, the sponsor needed insight into what current competitive offerings being utilized, competitive product codes, and a variety of insights regarding customer’s … Continue reading Voice of Customer Study
-
Go-To-Market Strategy
Situation: As a follow up to a pricing study, Kineticos was retained by a specialty laboratory to develop a comprehensive strategy designed to help the client double in revenue in the next 4 years. This engagement was split into two phases: the first phase was data gathering on key competitive, market, pipeline, and technology intelligence, … Continue reading Go-To-Market Strategy
-
Functional Process Improvement
Situation: A leading global contract research organization dissatisfied with their lab’s scientific affairs function retained Kineticos to conduct an operational review of the entire department and identify opportunities to increase the function’s value to the business unit. Process: Kineticos started by performing a thorough review of current processes, tools and organizational structure supporting the company’s … Continue reading Functional Process Improvement
-
Lab Integration Strategy
Situation: A global bioanalytical lab specializing in large-molecule bioanalysis was experiencing challenges while integrating with their large, geographically distant partner. The company recruited Kineticos to provide a 100-day strategic integration plan to ensure a smooth and expedited amalgamation of the two entities. Process: Kineticos commenced with a detailed review of the documentation provided by both … Continue reading Lab Integration Strategy
-
Central Lab Operational Excellence
Situation: A global contract research organization was experiencing operational challenges within the central lab causing the business unit to perform below sales and growth expectations. Kineticos was tasked with conducting a gap analysis and providing recommendations intended to increase operational efficiencies and ultimately boost sales and profit margin Process: Working closely with functional leaders within the … Continue reading Central Lab Operational Excellence
-
How Metrics Can Help Identify and Solve Operational Challenges
As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of operational challenges. Breakdowns in process can often by uncovered by process mapping; however, a commonly overlooked and significant contributing factor to both operational setbacks and advances is the effective use of metrics. This article from … Continue reading How Metrics Can Help Identify and Solve Operational Challenges
-
Growth by Acquisition in Life Sciences: Do You Have a Plan?
As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as Roche’s acquisition of Ariosa Diagnostics and LabCorp’s acquisition of Covance, bring to light an important question for decision makers in the life sciences industry: When it comes to growth by acquisition, what is your plan? … Continue reading Growth by Acquisition in Life Sciences: Do You Have a Plan?
-
Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships
Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping as part of a deal with the Children’s Hospital of Philadelphia (CHOP)1. The service offering will begin mid-November, allowing for more precise characterization of the gene sequence and potentially leading to expanded patient…
-
Role of Companion Diagnostics in Immuno-oncology Race Unfolding
Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies have put into oncology, especially the immuno-oncology therapies centered on PD-1. In previous blogs, I noted that BMS appeared to be leaning toward not incorporating a companion diagnostic for nivolumab (another anti-PD-1 therapy) in melanoma … Continue reading Role of Companion Diagnostics in Immuno-oncology Race Unfolding
-
Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth
Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based in St. Louis. Merck KGaA is offering to pay $140/share for Sigma-Aldrich for an enterprise value of $17 billion. The deal has been approved by the Board of Directors for both companies and is expected…
-
Outsourcing as Opportunity
An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced in pharma, it certainly is big news. By looking at the reasoning behind the layoffs, you get an indicator of the health of the overall industry. Currently, patent cliffs, weak pipelines, regulatory, and generic pressures … Continue reading Outsourcing as Opportunity